Enrollment Complete in Lipogems ARISE II Study
The ARISE I and II studies are designed to support Lipogems in obtaining a separate indication specifically for knee OA....
The ARISE I and II studies are designed to support Lipogems in obtaining a separate indication specifically for knee OA....
The company reached its target of 300 enrolled patients in the multicenter, prospective spinal fusion registry PROPEL....
At 12 months, 100% of participants with distal radius fractures treated in trial with NVDX3 bone graft demonstrated durable bone...
PliaFX Flo is a demineralized bone matrix combining fibers with a glycerol carrier. The graft flows directly from the syringe...
OsteoFlo HydroFiber leverages Web Interlace Technology, suspending particles within its fibers to prevent graft migration while ensuring optimal cohesiveness and...
Backpack is designed for optimization of cell proliferation and bone formation and is used in orthopedic and spinal fusion procedures....
FDA approved an expansion to its Phase I/II clinical program to include three spinal fusion indications and tripling the number...
Three of the company’s MagnetOs bone graft formulations are already indicated for use beyond spine procedures....
LDGraft is a combination product that delivers recombinant human bone morphogenetic protein-2 through a biodegradable polymer....
The FDA clearance allows NovaBone Putty to be used in the intervertebral disc space alongside FDA-cleared interbody fusion devices....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.